Evidence map›Paper›PMID 35084903›Full record

Trial reportPsychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors2022

Characterizing cannabis use reduction and change in functioning during treatment: Initial steps on the path to new clinical endpoints.

Jacob T Borodovsky, Michael J Sofis, Brian J Sherman, Kevin M Gray, Alan J Budney

Open access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.3field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Is it time for a cannabis harm reduction approach? Commentary on Sherman et al. (2022) and Borodovsky et al. (2022).Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Jacob T BorodovskyCenter for Technology and Behavioral Health.ORCID 0000-0001-7112-5677
Michael J SofisAdvocates for Human Potential, Inc.
Brian J ShermanDepartment of Psychiatry and Behavioral Sciences.ORCID 0000-0001-8097-3061
Kevin M GrayDepartment of Psychiatry and Behavioral Sciences.
Alan J BudneyCenter for Technology and Behavioral Health.
Centers for Behavioral Health · USAdvocates for Human Potential (United States) · US

Funding

Southern Consortium Node of the Clinical Trials NetworkU10DA013727 · NIDA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI BRADY, KATHLEEN T. · 2000 to 2015
$34.4M
Treatment Development & Evaluation CoreP30DA029926 · NIDA · DARTMOUTH COLLEGE · PI Lisa A. Marsch · 2011 to 2026
$21.5M
Training in the Science of Co-Occurring DisordersT32DA037202 · NIDA · DARTMOUTH COLLEGE · PI Lisa A. Marsch · 2014 to 2026
$4.7M
Leveraging Social Media to Develop the Cannabis Exposure Index (CEI), A Standardized Measure of Cannabis UseR01DA050032 · NIDA · DARTMOUTH COLLEGE · PI Jacob T Borodovsky, DEBORAH S HASIN · 2020 to 2026
$3.8M
Approach Bias Modification for the Treatment of Cannabis Use DisorderK23DA045099 · NIDA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI SHERMAN, BRIAN · 2018 to 2022
$927k
Assessing the Contribution of Alcohol and Psychotropic Medication Use to Upward US Injury and Poisoning TrendsF32AA027941 · NIAAA · WASHINGTON UNIVERSITY · PI BORODOVSKY, JACOB T · 2019 to 2020
$94k
NIAAA NIH HHS F32 AA027941NIDA NIH HHS K23 DA045099NIDA NIH HHS P30 DA029926NIDA NIH HHS R01 DA050032NIDA NIH HHS T32 DA037202NIDA NIH HHS U10 DA013727NIH HHS
6 · The paper itself

Abstract

Reduction-based cannabis use endpoints are needed to better evaluate treatments for cannabis use disorder (CUD). This exploratory, secondary analysis aimed to characterize cannabis frequency and quantity reduction patterns and corresponding changes in psychosocial functioning during treatment. We analyzed 16 weeks (4 prerandomization, 12 postrandomization) of data (

Indexed as

CannabinoidsCannabisMarijuana AbuseHumansSelf ReportCannabinoids

Identifiers

PMID35084903
PMCPMC9325921
OpenAlexW4210651347

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.